Apoptosis in the myocardium: Much is still expected

Expert Opinion on Therapeutic Targets

Volumn 7, Issue 1, 2003, Pages 61-69

  Umansky, Samuil R ^a   Tomei, L David ^a  

^a Xenomics Inc   (United States)

Author keywords

Apoptosis; Heart; Ischaemia; Myocytes; Therapeutics

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CASPASE INHIBITOR; CHLORIDE CHANNEL BLOCKING AGENT; CYCLOSPORIN A; CYSTEINE PROTEINASE; CYTOCHROME C; DNA FRAGMENT; LYSOPHOSPHATIDIC ACID; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; CELL DEATH; DNA REPAIR; DRUG EXPOSURE; DRUG TARGETING; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; HUMAN CELL; MEDICAL LITERATURE; MOLECULAR DYNAMICS; MOLECULAR MECHANICS; NICK END LABELING; OBSERVATION; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CARDIOVASCULAR AGENTS; CELL DIFFERENTIATION; CYSTEINE PROTEINASE INHIBITORS; DRUG DESIGN; ENDOTHELIAL CELLS; EVOLUTION; HUMANS; LYSOPHOSPHOLIPIDS; MYOCARDIAL ISCHEMIA; MYOCARDITIS; MYOCARDIUM; MYOCYTES, CARDIAC; NECROSIS; RATS; SIGNAL TRANSDUCTION;

EID: 0037312973     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.7.1.61     Document Type: Review

References (86)

1. THOMPSON CB: Apoptosis in the pathogenesis and treatment of disease. Science (1995) 267:1456-1462.
2. UMANSKY SR, TOMEI LD: Apoptosis in the heart. Adv. Pharmacol. (1997) 41:383-407.
3. DOCKRELL DH: Apoptotic cell death in the pathogenesis of infectious diseases. J. Infect. (2001) 42:227-234.
4. BENNETT MR: Apoptosis in the cardiovascular system. Heart (2002) 87:480-487.
5. IGNEY FH, KRAMMER PH: Death and anti-death: tumour resistance to apoptosis. Nat. Rev. Cancer (2002) 2:277-288.
6. TOMEI LD, COPE FO: Introduction. In: Apoptosis. The Molecular Basis of Cell Death. Tomei LD, Cope FO (Eds), Cold Spring Harbor Laboratory Press, New York (1991):1-3.
7. JAMES TN: Apoptosis in cardiac disease. Am. J. Med. (1999) 107:606-620.
8. ANVERSA P: Plasticity of the pathologic heart. Ital. J. Heart (2000) 1:91-95.
9. HAUNSTETTER A, IZUMO S: Future perspectives and potential implications of cardiac myocyte apoptosis. Cardiovasc. Res. (2000) 45:795-801.
10. BARR PJ, TOMEI LD: Apoptosis and its role in human disease. Biotechnology (1994) 12:487-493.
11. KANTER P, LEISTER KJ, TOMEI LD, WENNER PA, WENNER CE: Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms. Biochem. Biophys. Res. Commun. (1984) 118:392-399.
12. TOMEI LD: Apoptosis: a program for death or survival? In: Apoptosis: The Molecular Basis of Cell Death. Tomei LD, Cope FO (Eds), Cold Spring Harbor Laboratory Press, New York (1991):279-316.
13. KERR JFR, WYLLIE AH, CURRIE AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. (1972) 26:239-257.
14. WYLLIE AH, KERR JFR, CURRIE AR. The significance of apoptosis. Int. Rev. Cytol. (1980) 68:251-306.
15. GLUCKSMANN A: Cell deaths in normal vertebrate ontogeny. Biol. Rev (1951) 26:59-86.
16. CLARKE PG, CLARKE S: Nineteenth century research on naturally occurring cell death and related phenomena. Anat. Embryol. (1996) 193:81-99.
17. UMANSKY SR: The genetic program of cell death. Hypothesis and some applications: transformation, carcinogenesis, aging. J. Theor. Biol. (1982). 97:591-602.
18. METZSTEIN MM, STANFIELD GM, HORVITZ HR: Genetics of programmed cell death in C. elegans. past, present and future. Trends Genet. (1998) 14:410-416.
19. GROSS A, MCDONNELL JM, KORSMEYER SJ: BCL-2 family members and the mitochondria in apoptosis. Genes Dev. (1999) 13:1899-1911.
20. REED JC: Mechanisms of apoptosis. Am. J. Pathol. (2000) 157:1415-1430.
21. BARGONETTI J, MANFREDI JJ: Multiple roles of the tumor suppressor p53. Curr. Opin. Oncol. (2002) 14:86-91.
22. WILLIAMS JR, LITTLE JB, SHIPLEY WU: Association of mammalian cell death with a specific endonucleolytic degradation of DNA. Nature (1974) 252:754-755.
23. LOCKSHIN RA: The early modern period in cell death. Cell Death Differ. (1997) 4:347-351.
24. WALKER NI, HARMON BV, GOBE GC, KERR JF: Patterns of cell death. Methods Achiev. Exp. Pathol. (1988) 13:18-54.
25. RAFF MC, BARRES BA, BURNE JF, COLES HS, ISHIZAKI Y, JACOBSON MD: Programmed cell death and the control of cell survival. Philos. Trans. R. Soc. Lond B Biol. Sci. (1994) 345:265-268.
26. DUKE RC, OJCIUS DM, YOUNG JD: Cell suicide in health and disease. Sci. Am. (1996) 275:80-87.
27. AFANAS'EV VN, KOROL BA, MANTSYGIN YUA, NELIPOVICH PA, PECHATNIKOV VA, UMANSKY SR: Flow cytometry and biochemical analysis of DNA degradation characteristic of two types of cell death. FEBS Lett. (1986) 194:347-350.
28. TOMEI LD, SHAPIRO J, COPE FO: Apoptosis in C3H-10T1/2 mouse embryonic cells: evidence for internucleosomal DNA modification in the absence of double strand cleavage. Proc. Natl. Acad. Sci. USA (1993) 90:853-857.
29. KOK YJ, SWE M, SIT KH: Necrosis has orderly DNA fragmentations. Biochem. Biophys. Res. Commun. (2002) 294:934-939.
30. LEIST M, JAATTELA M: Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell Biol. (2001) 2(8):589-598.
31. BURSCH W. The autophagosomal-lysosomal compartment in programmed cell death. Cell Death Differ. (2001) 8(6):569-581.
32. SPERANDIO S, DE BELLE I, BREDESEN DE: An alternative, nonapoptotic form of programmed cell death. Proc. Natl. Acad. Sci. USA (2000) 97(26):14376-14381.
33. LOO DT, RILLEMA JR. Measurement of cell death. Methods Cell Biol. (1998) 57:251-264.
34. SARASTE A, PULKKI K: Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. (2000) 45:528-537.
35. STADELMANN C, LASSMANN H: Detection of apoptosis in tissue sections. Cell Tissue Res. (2000) 301:19-31.
36. UMANSKY SR, PISARENKO OI, SEREBRYAKOVA LI et al.: Dog cardiomyocyte death induced in vivo by ischemia and reperfusion. Basic Appl. Myol. (1996) 6:227-235.
37. UMANSKY SR: Apoptotic process in the radiation-induced death of lymphocytes. In: Apoptosis. The Molecular Basis of Cell Death. Tomei LD, Cope FO (Eds), Cold Spring Harbor Laboratory Press, New York (1991):193-208.
38. AFANASYEV VN, KOROL BA, MATYLEVICH NP, PECHATNIKOV VA, UMANSKY SR: The use of flow cytometry for the investigation of cell death. Cytometry (1993) 14:603-609.
39. VAN ENGELAND M, NIELAND LJ, RAMAEKERS FC, SCHUTTE B, REUTELINGSPERGER CP: Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry (1998) 31:1-9.
40. COHEN GM, SUN XM, SNOWDEN RT, DINSDALE D, SKILLETER DN: Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem. J. (1992) 286:331-334.
41. GOTTLIEB RA, BURLESON KO, KLONER RA, BABIOR BM, ENGLER RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J. Clin. Invest. (1994) 94:1621-1628.
42. SARASTE A: Morphologic criteria and detection of apoptosis. Herz (1999) 24:189-195.
43. NICOTERA P, LEIST M, FERRANDO-MAY E: Apoptosis and necrosis: different execution of the same death. Biochem. Soc. Symp. (1999) 66:69-73.
44. REUTELINGSPERGER CP, DUMONT E, THIMISTER PW et al.: Visualization of cell death in vivo with the annexin A5 imaging protocol. J. Immunol. Methods (2002) 265:123-132.
45. UCHIYAMA T, OTANI H, OKADA T et al.: Nitric oxide induces caspase-dependent apoptosis and necrosis in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol. (2002) 34:1049-1061.
46. KONG JY, RABKIN SW. Palmitate-induced apoptosis in cardiomyocytes is mediated through alterations in mitochondria: prevention by cyclosporin A. Biochim. Biophys. Acta (2000) 1485:45-55.
47. KOONIN EV, ARAVIND L: Origin and evolution of eukaryotic apoptosis: the bacterial connection. Cell Death Differ. (2002) 9:394-404.
48. APPLEBY DW, MODAK SP: DNA degradation in terminally differentiating lens fiber cells from chick embryos. Proc. Natl. Acad. Sci. USA (1977) 74:5579-5583.
49. ISHIZAKI Y, JACOBSON MD, RAFF MC: A role for caspases in lens fiber differentiation. J. Cell Biol. (1998) 140:153-158.
50. SCHER W, FRIEND G: Breakage of DNA and alterations in folded genomes by inducers of differentiation in Friend erythroleukemic cells. Cancer Res. (1978) 38:841-849.
51. TERADA M, NUDEL U, FIBACH E, RIFKIND RA, MARKS PA: Changes in DNA associated with induction of erythroid differentiation by dimethyl sulfoxide in murine erythroleukemia cells. Cancer Res. (1978) 38:835-840.
52. RUNGE MS, STOUFFER GA, SHEAHAN RG, YAMAMOTO S, TSYPLENKOVA VG, JAMES TN: Morphological patterns of death by myocytes in arrhythmogenic right ventricular dysplasia. Am. J. Med. Sci. (2000) 320:310-319.
53. GREEN DR, AMARANTE-MENDES GP: The point of no return: mitochondria, caspases, and the commitment to cell death. Results Probl. Cell Differ. (1998) 24:45-61.
54. KROEMER G, REED JC: Mitochondrial control of cell death. Nat. Med. (2000) 6:513-519.
55. SHI Y: Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell. (2002) 9:459-470.
56. ACEHAN D, JIANG X, MORGAN DG, HEUSER JE, WANG X, AKEY CW: Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell. (2002) 9:423-432.
57. NAGATA S: Apoptotic DNA fragmentation. Exp. Cell Res. (2000) 256:12-18.
58. KRAMMER PH: CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. (1999) 71:163-210.
59. ZHENG TS, SCHLOSSER SF, DAO T et al.: Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc. Natl. Acad. Sci. USA (1998) 95:13618-13623.
60. AMARANTE-MENDES GP, FINUCANE DM, MARTIN SJ, COTTER TG, SALVESEN GS, GREEN DR: Anti-apoptotic oncogens prevent caspase-dependent and independent commitment for cell death. Cell Death Differ. (1998) 5:298-306.
61. JANICKE RU, SPRENGART ML, WATI MR, PORTER AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. (1998) 273:9357-9360.
62. KUROKAWA H, NISHIO K, FUKUMOTO H, TOMONARI A, SUZUKI T, SAIJO N: Alteration of caspase-3 (CPP32/Yama/apopain) in wild-type MCF-7, breast cancer cells. Oncol. Rep. (1999) 6:33-37.
63. LEMAIRE C, ANDREAU K, SOUVANNAVONG V, ADAM A: Inhibition of caspase activity induces a switch from apoptosis to necrosis. FEBS Lett. (1998) 425:266-270.
64. WEIL M, JACOBSON MD, RAFF MC: Are caspases involved in the death of cells with a transcriptionally inactive nucleus? Sperm and chicken erythrocytes. J. Cell Sci. (1998) 111:2707-2715.
65. GREEN D: Apoptotic pathways: the roads to ruin. Cell (1998) 94:695-698.
66. OPPENHEIM RW, FLAVELL RA, VINSANT S, PREVETTE D, KUAN CY, RAKIC P: Programmed cell death of developing mammalian neurons after genetic deletion of caspases. J. Neurosci. (2001) 21:4752-4760.
67. LOCKSHIN RA, FACEY CO, ZAKERI Z: Cell death in the heart. Cardiol. Clin. (2001) 19:1-11.
68. NEUSS M, CROW MT, CHESLEY A, LAKATTA EG: Apoptosis in cardiac disease-what is it-how does it occur. Cardiovasc. Drugs Ther. (2001) 15:507-523.
69. CHANG LK, JOHNSON EM JR: Cyclosporin A inhibits caspase-independent death of NGF-deprived sympathetic neurons: a potential role for mitochondrial permeability transition. J. Cell Biol. (2002) 157:771-781.
70. SHIRAISHI J, TATSUMI T, KEIRA N et al.: Important role of energy-dependent mitochondrial pathways in cultured rat cardiac myocyte apoptosis. Am. J. Physiol. Heart Circ. Physiol. (2001) 281:H1637-H1647.
71. XU M, WANG Y, HIRAI K, AYUB A, ASHRAF M: Calcium preconditioning inhibits mitochondrial permeability transition and apoptosis. Am. J. Physiol. Heart Circ. Physiol. (2001) 280:H899-H908.
72. HOLLY TA, DRINCIC A, BYUN Y et al.: Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. Mol. Cell. Cardiol. (1999) 31:1709-1715.
73. OKAMURA T, MIURA T, TAKEMURA G et al.: Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc. Res. (2000) 45:642-650.
74. YAOITA H, OGAWA K, MAEHARA K, MARUYAMA Y: Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation (1998) 97(3):276-281.
75. MIZOGUCHI H, MAETA H, YAMAMOTO A, OE M, KOSAKA H: Amelioration of myocardial global ischemia/reperfusion injury with volume-regulatory chloride channel inhibitors in vivo. Transplantation (2002) 73:1185-1193.
76. DIAZ RJ, BATTHISH M, BACKX PH, WILSON GJ: Chloride channel inhibition does block the protection of ischemic preconditioning in myocardium J. Mol. Cell. Cardiol. (2001) 33:1887-1889.
77. NICOTERA P, ORRENIUS S: The role of calcium in apoptosis. Cell Calcium (1998) 23:173-180.
78. GU Y, GORELIK J, SPOHR HA, SHEVCHUK A, LAB MJ, HARDING SE et al.: High-resolution scanning patch-clamp: new insights into cell function. FASEB J. (2002) 16:748-750.
79. SINGH K, XIAO L, REMONDINO A, SAWYER DB, COLUCCI WS: Adrenergic regulation of cardiac myocyte apoptosis. J. Cell. Physiol. (2001) 189:257-265.
80. SAMAREL AM: IGF-1 overexpression rescues the failing heart. Circ. Res. (2002) 90:631-633.
81. SUN HY, ZHAO RR, ZHI JM: Insulin-like growth factor I inhibits cardiomyocyte apoptosis and the underlying signal transduction pathways. Methods Find. Exp. Clin. Pharmacol. (2000) 22:601-607.
82. MELKONYAN HS, CHANG WC, SHAPIRO JP et al.: SARPs: a family of secreted apoptosis-related proteins. Proc. Natl. Acad. Sci. USA (1997) 94:13636-13641.
83. FUJIO Y, NGUYEN T, WENCKER D, KITSIS RN, WALSH K: Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 101:660-667.
84. UMANSKY SR, CUENCO GM, KHUTZIAN SS, BARR PJ, TOMEI LD: Post-ischemic apoptotic death of rat neonatal cardiomyocytes. Cell Death Differ. (1995) 2:235-241.
85. UMANSKY SR, SHAPIRO JP, CUENCO GM, FOEHR MW, BATHURST IC, TOMEI LD: Prevention of rat neonatal cardiomyocyte apoptosis induced by simulated in vitro ischemia and reperfusion. Cell Death Differ. (1997) 4:608-616.
86. KARLINER JS, HONBO N, SUMMERS K, GRAY MO, GOETZL EJ: The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J. Mol. Cell. Cardiol. (2001) 33:1713-1717.